...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >A study of drug utilization trends in acute coronary syndrome in intensive cardiac care unit at a tertiary care hospital, Mysore
【24h】

A study of drug utilization trends in acute coronary syndrome in intensive cardiac care unit at a tertiary care hospital, Mysore

机译:三重医院迈索尔重症监护病房急性冠脉综合征药物利用趋势的研究

获取原文
           

摘要

Background: Acute Coronary Syndrome (ACS) is an emergency condition where usage of many drugs during its management in ICCU is common. This could be a potential cause for Polypharmacy, Potential Drug-Drug Interactions and increased Cost Burden on patients. The objective of the study was WHO criteria for prescription like, 1) Average number of drugs per prescription, 2) Percentage of drugs prescribed by Generic name, 3) Percentage of drugs with Injections prescribed, 4) Percentage of prescriptions with Antibiotics and 5) Percentage of drugs prescribed from the WHO Essential Drugs List. Methods: After obtaining approval from Institutional Ethics Committee, an observational study was carried out among 125 patients in a tertiary care hospital, Mysore. Patients diagnosed with ACS admitted in Intensive Cardiac Care Unit (ICCU) for initial 48 hrs were included in the study. The prescriptions were analyzed for WHO criteria for prescription. The results were analyzed using Descriptive Statistics and T- test. Results: In our present study the most common diagnoses were found to be ACS- Anterior wall myocardial infarction (36.8%) and ACS-Inferior wall myocardial infarction (32.8%). Hypertension (35.2%) and Type 2 diabetes mellitus (29.6%) were the frequently associated co-morbid conditions. Antiplatelet drugs (100%) and Hypolipidemic drugs (100%) were the most commonly prescribed, followed by Anti coagulants (94.4%). The average number of drugs per prescription was 9.09±2.17. Percentage of drugs prescribed by generic names was 37.29%. The percentage of drugs prescribed from essential drug list was 50.84%. Conclusions: The present study provides valuable insight about the overall pattern of drugs used in Acute Coronary syndrome. Physician should be encouraged to prescribe drugs with generic name.
机译:背景:急性冠状动脉综合征(ACS)是一种紧急情况,在ICCU的治疗期间经常使用许多药物。这可能是多元药房,潜在的药物-药物相互作用和患者负担增加的潜在原因。这项研究的目标是WHO的处方标准,例如:1)每个处方的平均药物数量; 2)通用名称所规定的药物百分比; 3)注射剂所占的药物百分比; 4)抗生素处方所占的百分比和5) WHO基本药物清单中规定的药物百分比。方法:在获得机构伦理委员会的批准后,对迈索尔三级医院的125名患者进行了观察性研究。该研究包括在最初的48小时内在重症监护病房(ICCU)入院诊断为ACS的患者。针对世界卫生组织的处方标准对处方进行分析。使用描述性统计和T检验分析结果。结果:在本研究中,最常见的诊断为ACS-前壁心肌梗塞(36.8%)和ACS-下壁心肌梗塞(32.8%)。高血压(35.2%)和2型糖尿病(29.6%)是常见的合并病。最常用的处方是抗血小板药(100%)和降血脂药(100%),其次是抗凝药(94.4%)。每个处方的平均药物数量为9.09±2.17。通用名药物所占百分比为37.29%。从基本药物目录中开出的药物百分比为50.84%。结论:本研究提供了关于急性冠脉综合征所用药物总体模式的宝贵见解。应鼓励医师开具通用名称的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号